Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Access to quality-assured antimicrobials is regarded as part of the human right to health, yet universal access is often undermined in low-income and middle-income countries. Lack of access to the instruments necessary to make the correct diagnosis and prescribe antimicrobials appropriately, in addition to weak health systems, heightens the challenge faced by prescribers. Evidence-based interventions in community and health-care settings can increase access to appropriately prescribed antimicrobials. The key global enablers of sustainable financing, governance, and leadership will be necessary to achieve access while preventing excess antimicrobial use.

Original publication




Journal article



Publication Date





188 - 198


Anti-Bacterial Agents, Bacterial Infections, Delivery of Health Care, Developing Countries, Diagnostic Tests, Routine, Drug Resistance, Microbial, Drugs, Generic, Evidence-Based Practice, Financing, Organized, Health Services Accessibility, Humans, Inappropriate Prescribing, Point-of-Care Systems, Practice Guidelines as Topic, Primary Prevention, Quality Control, Vaccination